| 000 | 00953cam a2200277 i 4500 | ||
|---|---|---|---|
| 008 | 760107s1975 dcu b 000 0 eng | ||
| 020 | _a0844731676 | ||
| 040 |
_aDLC _cDLC |
||
| 050 | 0 | 0 |
_aRS122 _b.W37 |
| 082 | 0 | 0 |
_a615.19 _bWAR |
| 100 | 1 | _aWardell, William M. | |
| 245 | 1 | 0 | _aRegulation and drug development / |
| 260 |
_aWashington : _bAmerican Enterprise Institute for Public Policy Research, _c1975. |
||
| 300 | _a181 p. ; | ||
| 504 | _aIncludes bibliographical references. | ||
| 520 | _aExamines the regulations that have evolved from the therapeutic drugs and the impact of those regulations on new development and therapeutic practice, with special reference to the United States. | ||
| 590 | _aoif 05/08/16 | ||
| 591 | _aLoan | ||
| 650 | 0 | _aDrug development | |
| 650 | 0 | _aDrugs | |
| 650 | 0 | _aPharmaceutical industry | |
| 650 | 0 | _aPharmaceutical policy | |
| 700 | 1 | _aLasagna, Louis, | |
| 942 |
_2ddc _cBOOK |
||
| 949 | _a615.19 WAR | ||
| 999 |
_c4253 _d4253 |
||